Abstract 5062: Evaluation of genetic mutations in non-small cell lung cancer patients
Miles Rothstein(Prisma Health), Anna V. Blenda(University of South Carolina), Julie Martin(Prisma Health), Ella G. Markalunas(Brown University), Lorie Allen(Prisma Health), William J. Edenfield(Prisma Health), Phillip Broughton(Prisma Health), Avery Funkhouser(National Institutes of Health)
Cited by 0
Related Papers
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors
|Journal for ImmunoTherapy of Cancer|2020|117
Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer
|Cancers|2021|36
Evaluation of BCL6 and SIRT1 as Non-Invasive Diagnostic Markers of Endometriosis
|Current Issues in Molecular Biology|2021|33